Last Updated: November 9, 2026

Patent: 8,057,794

Summary for Patent: 8,057,794

Title:	Antibody molecules which bind to human IL-17
Abstract:	The invention relates to antibody molecules having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Inventor(s):	Stephen Edward Rapecki, Andrew George Popplewell, Ralph Adams
Assignee:	UCB Biopharma SRL
Application Number:	US12/306,251
Patent Claims:	see list of patent claims

Details for Patent 8,057,794

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Sanofi Vaccines Canada Ltd.	TENIVAC	tetanus and diphtheria toxoids adsorbed	Injection	103171	November 3, 2003	8,057,794	2027-06-25
Sanofi-aventis U.s. Llc	ZALTRAP	ziv-aflibercept	Injection	125418	August 3, 2012	8,057,794	2027-06-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 8,057,794

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Argentina	061538	⤷ Start Trial
Brazil	PI0713300	⤷ Start Trial
Canada	2655874	⤷ Start Trial
Chile	2007001840	⤷ Start Trial
China	101501072	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.